 Product Search |
|
| Input Product Name Or Cas No. |
| Category |
| Products |
 triphenylsulfonium 1,1-difluoro-2-((12-( |
| triphenylsulfonium 5’,5’,6’,6’-t |
| triphenylsulfonium 12-((2,4,6-triiodophe |
| Sulfonium, triphenyl-, 2,2,3,3,3-pentafl |
| mono(triphenylsulfonium) mono(2-hydroxy- |
| 1-Methylcyclopentyl 5-ethenyl-1-naphthal |
| 1-Ethylcyclopentyl 5-[(2-methyl-1-oxo-2- |
| 3,3′-(1,1-Dioxido-3H-2,1-benzoxathiol- |
| 2-oxohexahydro-2H-3,5-methanocyclopenta[ |
| 5-oxo-4-oxatricyclo[4.3.1.13,8]undecan-2 |
| 1-Ethylcyclopentyl 4-formyl-1-naphthalen |
| 2-((2-ethyladamantan-2-yl)oxy)-2-oxoethy |
| tris(4-fluorophenyl)sulfonium ((7,7-dime |
| 3′,6′-Bis(methoxymethoxy)spiro[isobe |
| 3’,6’-di-tert-butoxy-3H-spiro[isoben |
| 3,3-Bis[4-(methoxymethoxy)-1-naphthaleny |
| 3,3-Bis[4-(1,1-dimethylethoxy)-1-naphtha |
| 1-methylcyclopentyl 2-hydroxy-6-vinylben |
| 2-(2-(benzyloxy)ethyl)-2-propylpropane-1 |
| diethyl 2-(2-(benzyloxy)ethyl)-2-propylm |
| 4-(7-bromo-2,3-dihydro-1H-inden-4-yl)phe |
| 3,3-bis(((tert-butyldimethylsilyl)oxy)me |
| 4-Bromo-2,3-dihydro-7-iodo-1H-indene |
| 2-Butoxy-1,2-oxaborolane |
| 2-hydroxy-1-(4’-(methacryloyloxy)-[1,1 |
| Decahydro-2-naphthalenyl 2-hydroxybenzoa |
| 1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl |
| 2-Cyclohexylethyl 2-hydroxybenzoate |
| 3,3,4-trimethylbicyclo[2.2.1]heptan-2-yl |
| benzyl 4-isopropyl-3-(methacryloyloxy)be |
| 2,6-diethoxyphenyl methacrylate |
| decahydronaphthalen-2-yl 2-(methacryloyl |
| 1,2,2-trimethylcyclohexyl acrylate |
| diallyl phenylphosphonate |
| 4-(tert-butyl)-2-(5-(tert-butyl)-2-oxo-2 |
| 2,6-di-tert-butyl-4-(mercaptomethyl)phen |
| 1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl 2 |
| 1,3,3-Trimethylbicyclo[2.2.1]hept-2-yl 2 |
| 4-((methacryloyloxy)methyl)benzoic acid |
| Benzene, 4-ethenyl-2-methoxy-1-(1-methox |
| Benzoic acid, 4-ethenyl-, 1-(1,1-dimethy |
| Benzoic acid, 4-ethenyl-, 2,2-dimethylpr |
| 1-Ethenyl-3-(2-methylpropoxy)benzene |
| 1-(Cyclohexyloxy)-3-ethenylbenzene |
| Benzoic acid, 4-ethenyl-, 1,1,2-trimethy |
| 1-Ethenyl-2,4-bis(methoxymethoxy)benzene |
| 2H-Pyran, 2,2′-[(5-ethenyl-1,3-phenyle |
| 1-Butoxy-3-ethenylbenzene |
| 1,2-Benzenediol, 4-ethenyl-, 1,2-dibenzo |
| 1,2,3-Benzenetriol, 5-ethenyl-, 1,2,3-tr |
|
| Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| Rovathin601 | 1-Pyrenylboronic acid | 164461-18-1 | 97% |
| Rovathin602 | 9H-Fluoren-9-ol, 2,7-dibromo-9-phenyl- | 132717-37-4 | 97% |
| Rovathin603 | 9,10-Bis(2-naphthyl)anthracene | 122648-99-1 | 97% |
| Rovathin604 | Fluoren-2-amine, 9,9-dimethyl- | 108714-73-4 | 97% |
| Rovathin605 | 2-Bromo-9,9-dimethylfluorene | 28320-31-2 | 97% |
| Rovathin606 | 1-Amino-4-fluoronaphthalene | 438-32-4 | 97% |
| RovathinS701 | 9-Bromo-10-(naphthyl-2-yl)anthracene | 474688-73-8 | 97% |
| RovathinS702 | 2,7-Dibromo-9,9-dimethylfluorene | 28320-32-3 | 97% |
| RovathinS703 | 10,10'-Dibromo-9,9'-bianthryl | 121848-75-7 | 97% |
| Rovathin607 | Buflomedil Hydrochloride | 35543-24-9 | EP |
| Rovathin608 | Nisoldipine | 63675-72-9 | JP/CP |
| Rovathin609 | Ozagrel hydrochloride | 78712-43-3 | JP/CP |
| Rovathin610 | Atracurium Besylate | 64228-81-5 | BP2004/USP28 |
| Rovathin611 | Bupivacaine hydrochloride | 14252-80-3 | USP29/EP |
| Rovathin612 | (S)-(-)-Bupivacaine hydrochloride | 27262-48-2 | USP29 |
| Rovathin613 | (S)-(-)-Bupivacaine hydrochloride | 27262-48-2 | 98% |
| Rovathin614 | Ropivacaine hydrochloride | 98717-15-8 | USP29 |
| Rovathin615 | Adefovir Dipivoxil | 142340-99-6 | |
| Rovathin616 | diisopropylamine dichloroacetate | 660-27-5 | JP |
| Rovathin617 | Amifostine | 20537-88-6 | USP29 |
| Rovathin618 | Folinic acid, calcium salt | 1492-18-8 | USP29 |
| Rovathin619 | Calcium levofolinate | 80433-71-2 | EP |
| Rovathin620 | cisplatin | 15663-27-1 | USP |
| Rovathin621 | Cytarabine | 69-74-9 | USP |
| Rovathin622 | Docetaxel | 114977-28-5 | 98% |
| Rovathin623 | Etoposide | 33419-42-0 | USP |
| Rovathin624 | Gemcitabine hydrochloride | 122111-03-9 | USP28 |
| Rovathin625 | Imatinib | 220127-57-1 | |
| Rovathin626 | Irinotecan | 100286-90-6 | |
| Rovathin627 | Lentinan | 37339-90-5 | USP |
|
|
|
|
